Literature DB >> 3811233

Nonproductive, cell-associated virus exists before the appearance of antiviral antibodies in experimental measles encephalitis.

D R Carrigan, C M Kabacoff.   

Abstract

The ability of measles virus to induce a cell-associated state of infection in the central nervous system (CNS) plays an important role in the pathogenesis of subacute sclerosing panencephalitis (SSPE), a fatal disease of children and young adults. The mechanism by which such an infection state is established is unknown, but several hypotheses have been proposed. One of these suggests that antiviral antibodies induce the nonproductive infection state by a process termed antigenic modulation. Results presented here demonstrate that antigenic modulation is not involved in the induction of a cell-associated CNS infection in newborn hamsters by the LEC strain of SSPE derived measles virus. This follows from the finding that nonproductive, cell-associated virus can be isolated from infected CNS tissues prior to the appearance of antiviral antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3811233     DOI: 10.1016/0042-6822(87)90452-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Identification of interferon-resistant subpopulations in several strains of measles virus: positive selection by growth of the virus in brain tissue.

Authors:  D R Carrigan; K K Knox
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.

Authors:  A Hirano
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Identification of a nonproductive, cell-associated form of measles virus by its resistance to inhibition by recombinant human interferon.

Authors:  D R Carrigan; C M Kabacoff
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.